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Ptq ftOOLO MY'
J •H. Biqclo\-J and N .J..Glasn
1. Purpose
From our proposed study on screenina for cervical cancer,
we expect to obtain guidelinps for iroproving the design of
cervical cancer ｳ ｣ ｲ ･ ･ ｮ ｩ ｮ ｾ programs. This can be accomplished
by achieving four intermediate obiectives.
a) ｒ ･ ｳ ｯ ｬ Ｌ Ｌ ｾ ＿ important uncertainties in our knowleftgf!
of the natural history of cervical cancer.
b) Elucidate relations between design factors of a
screening program and the composition of the
population which volunteers to be ｳ ｣ ｲ ･ ･ ｮ ･ ｾ Ｎ
c) Formulate an optimization morlel using information
developed in· the first bolO activi ties. '1'his ｲ ｲ ｴ ｯ Ｈ ｨ ｾ 1
would choose an optimal screening policy aiven an
assumed stearly-state populntion and qisen variou3
levels of resources.
.
d) CreClte a simulation monel (o:r. adapt an existina on2,
e. q. Knox [1,2 J) to' st
'
Jdy questions of ｴ ｩ Ａ Ｑ Ｚ ･ Ｍ ｰ ｨ Ｚ Ｇ Ａ Ｚ Ｚ ｾ ir.cr
and implementation of t.he policies developed in the
third activity.
'The methoGs He .antic:i.p<it.e usinq ano thp. data He will ｲ ･ ｱ ｵ ｩ ｮ ｾ
for each of the four objectiv0s arc discussed in the next
foar sections.
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In its simplest conception, cancer of uterine cervix is a
disCi1Sp. thctt pr0C:1Tp.ss('S thronqh early stClqCS (dysplasia, carcinoma
in-situ) to i1 late stage (invasive cancer). In its early stages,
the disease is asymptomatic, hence women with these conditions
'viII not ordinarily present themselves for treatment. Ho'vever,
cases treated early have a much hetter prognosis than cases left
untreated until the invasive stacre.
The PAP smear is a simple, painless, and inexpensive test
that will detect cases of dysplasia and carcinoma in-situ with
high reliability. This test has been applied to vast numhers
of apparently healthy women. Large numbers of cases of dysplasia
and carcinoma in-situ have been discovered and prevented from
progressing to the invasive stage. Rut mortality from cancer
of the cervix has not been dramatically reduced, as proponants
of such screeninq ,activities had predicted, even in places where
virtually the entire population has been repeatedly screened.
One can explain these disappointing results, as does
Ashley [3,41, by sugqesting that some cases of dysplasia or
carcinoma in-situ will progress very rapidly to invasive
carcinoma, and hence pass through the early staqes between
successive screenings. Ashley also suggests that ｴ ｨ ･ ｳ ｾ "rapid"
cases are the ones with the poorest procrnosis. Certainly, the
distribution of d'vell times in the in-si tn stage will affect
It
Furthermore, Ashley [3], Green [5J, and others suggest that
a substantial proportion of early cases may spontaneously clear up,
ｾ ｡ ｾ ｨ ･ ｲ than progress to invasisve carcinoma. (This view is not
universal. See, e.g. Harron & Richart ｛ ｾ Ｎ Ｉ We are faced, therefore,
wi th the ｰ ｲ ｯ ｢ ｬ Ｈ ｾ ｭ of estimating the distribution of d,"ell times, in-s i tu.
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not of all ca8es, but only of that suhset of cases '''hich will
progress to clinically invasive cervical carcinoma.
Heretofore, only the mean of thrs distribution has heen
estimated, and that from aqe dependent ｩ ｮ ｣ ｩ ､ ･ ｮ ｣ ｾ and prevalence
data. Such a procedure can he criticized on many qrounds.
i) No satisfactory means has been proposed for inc'le-
pendently estimating the nEans of those cases which
progress to invasive cancer, and those cases which
spontaneously underqo remission. One must assume,
for example, that the mean. tines spent hy either
type of case in dysplasia plus carcinoma in-situ
are identical.
ii) PaIse neqative smears can distort the incidence
of carcinoma in-situ. Even when adjustments are
made due to this factor,--for example by estimating
incidence from cases in which a positive response
was proceeded by at least two negative responses,
as in l7]--the problem still exists. After all,
nothinq prevents the first of the ｮ ･ ｾ ｡ ｴ ｩ ｶ ･ responses
'from being a 'true' negative, and the second from
being false.
iii) Inaccurate classification of cases of clinically
invasive cervical carcinoma as cancer of the corpus
uterus, or inclusion of these cases in the category
•
"cancer of the ｵ ｴ ｣ ｾ ｵ ｾ unspccifiGd", will distort ones
estimate of the incidence of invasive cancer of the
cervix. Campbell [8J discusses this difficulty.
iv) 'J'he computations of mean d..,ell time aSSllme that
women born in different years will have the ｳ ｡ ｾ ･
age-dependent incidence and pr.evalence of both
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carcinoma in-situ Rnd invasive cancer. 'T'here is
strono ｣ ｶ ｩ ､ ･ ｮ ｣ ･ ｾ e.o. 19.101 that this is not true.
L. . i J .
Incidentally, this"cohort effect" offers an alter-
native explanation of the data that lead ｾ ｳ ｨ ｬ ･ ｹ to
conclude that some cases undergo spontaneous
ｲ ･ ｾ ｩ ｳ ｳ ｩ ｯ ｮ Ｌ and that other cases become invasive
with virtually no intervenino carcinoma in-situ
stage.
These criticisms point out the need for a direct method for
computing the in-situ d'''ell time ､ ｩ ｾ ｴ ｲ ｩ ｢ ｜ Ｎ ｬ ｴ ｩ ｯ ｮ of progressive
cases (cases that progress to invasive cancer).
The most satisfactory direct measurements would he obtained
by leaving women with positive smean; untreated until they
progress from dysplasia or carcinoma in-situ to invasive carcinoMa.
Ethical ｣ ｯ ｮ ｳ ｩ ､ ･ ｲ ｾ ｴ ｩ ｯ ｮ ｳ prevent this being done, although
occasionally a woman will refuse treatment and·hence voluntarily
provide just such a case. Sprigqs ｛ ｬ ｾ has ｣ ｯ ｬ ｬ ･ ｾ ｴ 13 such
cases, in which no treatment and no hiopsy were performed,and
each of which has been followed for at least three years. However,
the series is small and probahly biased. towards cases that pro-
voluntarilv
gress to invasive cancer. (These, ｾ ｩ ｮ ｣ ･ they often appearAfor -
treatment, are easier to f01l0'·' up.}
Some studies attemptinq
Other att:effiJ5t3 e-t direct measurements of this kind will
..
typically treat the subjects once the the staqe carcinoma in-situ
is reached, rather than allowino suhjects to progress to invasive
cancer. This is the case in the Barron & Richart [6J study, which
thus provides insight only into the elwell time c'iistribution in
the stage dysplasia. ｾ ｲ stucties, for example' Peterson [12],
Jordan, Bader and nay [13], and Niehnras [14J ' have fol-l-oHec1
women beyond the stage dysplasia and through carcinoma in-situ
-5-
but they hiwe all chosen to confirm ·the cytoloqic diaqnosis with
, , ,..... f. the histoloa.ici11 section:;.
;J ｲ ＾ ｩ Ｈ Ｉ ｰ ｾ ｹ ano !,;llh,,(OC!uent (:,,:.'1"'1 nnt:;,on 'I'
, may i an alreaoy invasiveIt is argued, however, that the bl0pSy m .5S
, 11 l'f very 11'ttle tissue i.s taken, or that it maycancer, especla y
remove most or all of the tumor, especially if much tissue is
removed.
tl11' s last POl'nt is the fact that one form ofSupporting
biopsy, the so-called cone hiopsy, is recommended by some as
treatment for carcinoma in-situ (for example, see noyd et al. [15J '
C k r'..,6,'J). E.Vl' r1ently, unless ｾ ｰ ｲ ｩ ｡ ｱ ｳ Ｇ [J.11and Krieger and Mc ormac. l -
t of this kino will notstudy can be augmented, direct rneasuremen .5
f th l'n-sl'ttl dwell time distribution ofyield an estimate o. e .
, . at J.east certain that such an estimateprogressive cases. It lS
cannot be made soon from such data.
We believe, however, that this distribution, as well as
other quantities of interest, can be estimated directly from
data that is routinely collected hy all screening programs.
These data are the hirthdate,and the dates and results of each
PAP smear, for every y7Qman who has participated in the program.
Also recorded is whether and when the woman contrated invasive
cancer of the cervix, despite screening.
One quantity we can estimate from those data ｩ ｳ ｾ ｴ ｨ ･ false-
negative rate for the PAP smear. The false-negative rate is
the proportion of smears taken from women with carcinoma in-
situ, which yield negative results. We estimate this quantity from
the manner in which the number of cases detected per screeninq
decreases as women are screened more and more times.
A group of women, prior to being screened for the first time,
will contain a backlog of cases which have yet to nrogress to
invasive cancer. The first screeninq will detect a fraction of
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those equal to one minus the false-neqative rate. The second
screening will detect the same fraction of the cases which apnear
between the two screeninqs, plus that fraction of the remaininq
backlog. After many screenings each new screeninq will detect
the same number of cases as annear ｨ ･ ｴ ｾ ｬ ･ ･ ｮ successive screeninqs.
(Some cases that appear between screenings will be missed, but
their number will be made up from cases which were missed earlier,
and are detected by the present screening.) The chanqe in the numher
of cases detected will be slow if the fulse-neqative rate is
high, because the initial backlog will not be depleted quickly.
ｃ ｯ ｮ ｶ ･ ｲ ｳ ｾ ｬ ｹ Ｌ a low false-negative rate implies a rapid ｣ ｨ ｡ ｲ ｩ ｾ ･ ｩ ｮ Ｎ ｾ ｨ ･
number of cases detected. A crude estimate OF the faJse-neqative
rate is 0.3, based on thie idea and on the limited data given in
W.
A second quantity that we can estimate from these data is the
in-situ dwell time distribution for all cases, including hoth
progressive cases and sham cases (cases that spontaneously disappear).
The method of estimation relies on the followinq fact. Once the
false negative rate is known, then this overall dwell-time
distribtiion could be used to estimate the numbers of in-situ
cases that one would expect to be detected by the screening
program. ｾ ｯ ｲ ･ than this, one could estimate how many of these
cases should be detected if screeninq occurred five years apart, or
two years apart, or at any other interval. A knowledge of the
frequency distribution of the various screening intervals in the
actual screening program would then yield an expected detection
rate.
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We propose to invert this re'lationship. Instead of using
the dwell-time distribution to estimate the detection rate, we
will use the rates of detection in ､ ｩ ｦ ｦ ･ ｲ ･ ｮ ｾ screeninq intervals
to estimate the dwell-time distribution. Because the equations
describing this relationship are linear, the inversion process
is theoretically well-understood and computationaly ｾ ･ ｡ ｳ ｩ ｨ ｬ ･ Ｎ
The third quantity we can estimate is the in-situ dwell-time
distribution of progressive cases. For this we will use data on
the few invasive cancers that occur among the screened population.
Siven the dwell-time distribution, one could compute the expected
number of invasive cases that would occur, at each interval of
time after a ｳ｣ｲ･･ｮｩｾｧ test. As hefore, this relation is linear
and could be inverted. However, the number of these cases is
very much smaller than the number of cases arrested at the in-
situ stage (less than 100 cases of invasive cancer, versus
thousands of cases of carcinoma in-situ in reference U- 7J ) •
Thus a method that estimates only the expected value of the
distribution is probably not adequate in this case. We anti-
cipate using a Baysian estimation technique, with a ｵｮｩｦｯｾ
prior distrihution for selected points on the in-situ dwell-
time distribution of proqressive cases.
Note that the distrihution derived in this way is the dwell-
time distribution for cases destined to become invasive. Cases
which undergo spontaneous remission do not influence the result.
Note also that the survival times of these invasive cases offer
in",+-",\ Ｎｾ .
froPl l17J suggests that pro(Jnosis is in(1ependent of ､ ｜ ｾ Ｑ ･ ｬ ｬ time,
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but this vievl is disputerl by Lawson [J RJ .) Pinally, note that
t.Ile same procedure Ci3.n be ｣ ｡ ｲ ｲ ｩ Ｎ ｾ Ｈ Ｑ out on suh!;ets of the plIpnlat.ion I
for example to test whether cases in older women tend to proqress
faster than those in younqer wonen, as ｾ ｳ ｨ ｬ ･ ｹ [4 1contenns.
To carry out these tasks, we will need the followinq data
on as many women as possible. A woman is eligible to be in-
eluded in the study if she has had at least one PAP smear, or
if she has had cancer of the cervix, or if she has had a
hysterectomy, or, of course, any combination of these. For
each woman in the study we shall need:
1. Birth date
2. Dates and results of each PAP smear (if anv). Possible
results are:normal, dysplasia, carcinoma in-situ, smear
unsatisfactory.
3. If the woman has had invasive cervical carcinoma, the
date it was diaqnosed and the stage (WHO classification)
at diaqnosis. Ne also would like to kno,,",' the treatnent
used and the lenqth of subsequent survival.
4. If the woman died of a cause other than uterine cancer,
the date of death.
5. If the woman underwent a hysterectomy for reasons other
than cancer, or for a cancer other than cervical cancer,
we wish to know it and the date of the operation.
The sources for this data will undoubtally be one or more
of the large cervical cancer screening programs. ｣ ｡ ｭ ｰ ｢ ･ ｬ ｬ ｾ ｝
suggests a number of sources in 14 different countries. The
British Columbia program [171 ｩｾ anotheftossible source, as
are several efforts in the United States, e.g. San Diego [7] ,
f1 emphis [19], and Olmstead County [20-22]. Our personal contacts
with Dr. Knox, and with Dr. ｾ ｡ ｲ ｩ ｮ of WHO, make us optimistic that
one can obtain access to at least some of this information.
J. ｐ ｾ ｲ ｴ ｩ ｣ ｩ ｰ ｾ ｴ ｩ ｯ ｮ
nne of the prime determinants of the yield of any screeninq
ｙ Ｇ ｜ ｾ ｾ ｾ Ｂ Ｂ ｾ Ｂ Ｇ Ｂ Ｌ Ｎ ［ ｾ +-h" T"'_,......_ ....... _ .... ..; ............ _.f= ..... ""'- .... ---- ..... --r.... '- ..... .:_-t .. ｾ｜ＮＬＬﾷＭＧｾ .... ｾ .. ｬｾ ..........l '-J.J."- ,.. .. .L.LJt·.... -.. .. .L'-..L.'--'ll L.I_'_ '-JI..'-_ Ｇ Ｍ ｾ ... 1'-1'-'- t/VJU..L<:"-_J.Vii ••h _WlJ\J
to be screened. Experience in attractinq participation, in the
absence of compulsion, has varied areatly between proqrams,
countries and demoqraphic groups. ]\t a recent ｾ Ｇ Ｗ ｈ ｏ syT1posium [23J
participants ci tea response rates for cervical ｣ ｡ ｮ ｣ Ｈ ｾ ｲ screeninq
programs as low as 25% for women over 35 years of aqe. In a
stuoy of screeninq in qeneral practice in the UK, however, a
response rate of over 90% was achieved [24J.
\vith rates varyinq as qreatly as this it is clearly of
importance (a) to isolate the factors affectinq participation,
(b) to establish the size of their effects,and (c), where
possible, to estimate the cost of achievinq chanqes in the
participation rate by acting directly or indirectly on some
of these factors.
Many of these factors ｵ ｮ ､ ｯ ｵ ｾ ｴ ･ ｯ ｬ ｹ interact, but, at least
for analytical purposes, they can he divided into
1. Demographic Characteristics
2. Attitudinal Factors
3. Organizational and Institutional Characteristics
These cateqory headings are somewhat imprecise hut are in-
tended to correspond rouqhly to three groups of which aroup J
is outside the decision-maker's ｣ ｯ ｮ ｴ ｲ ｯ ｬ ｾ ｱ ｲ ｯ ｵ ｰ 2 is capRhle of
being altered, hut the precise ｾ ･ ｴ ｨ ｯ ｾ ｳ and effects are not too
clear ana the effect may not be fully felt for some ｴ ｩ ｭ ･ ｾ while
group 3 contains those factors which are more directly under the
decision-maker's control and whose impact on the response rate
ｾ ｌ ｳ some,,,hilt more direct and certain.
There is not a great deal of ｮ ｵ ｬ Ｉ ｬ ｩ ｳ ｨ ･ ｾ ｾ ｡ ｴ ｡ on participation
14)-
ｲ ､ ｨ ｾ ｳ hy dcmoqraphic charClctct'istics. In the case of cervi cal
off with age. In the older nne qroups these rates often fall to
as lm'l as ｯ ｮ Ｈ ｾ Ｍ ｴ ｨ ｩ ｲ ､ of those in the younqer aqe-qroups [2 ｾ ｊ [25] •
It is not clear, hm'lever, that the percentaqe returning for a
se<?ond screeninq varies greatly between aqe-gronps [26J.
In the case of ｾ ｮ ｬ ｴ ｩ ｰ ｨ ｡ ｳ ｩ ｣ screening there also appears to be
a tendency for participation to falloff with age, althouah here,
too, tlw results are someHhat unclear [27J, Hi th the effect
being more pronounced amonq white fewales ｡ ｮ ｾ least pronounced amana
black fema les.
When measure of social class are ｵ ｳ ･ ｾ Ｌ participation rates
are also found to decline ｦ ｲ ｯ ｾ hiaherclass to lower class
groups, with the response to cervical cancer screening heina
as much as one-third lower amana women whose ｨ ｵ ｳ ｨ ｡ ｮ ｾ ｳ have
.'
lm'l-statns occupations [25J. 1\ similar effect has been observec1
in nultiphasic screenina. . prepaidIn a l\!aslnnaton n. c. ?)f'(}DAFee. aroup
practice consistina mainly of aovernment workers, ahout 50%
avail themselves of annual ･ ｸ ｡ ｾ ｩ ｮ ｡ ｴ ｩ ｯ ｮ ｳ Ｌ while intensive ･ ｾ ｦ ｯ ｲ ｴ ｳ
to induce ｾ ･ ｲ ｮ ｨ ･ ｲ ｳ of a hardcore poverty group in '-"efi1phis,
Tennessee to underao screenina ･ ｸ ｡ ｾ ｩ ｮ ｡ ｴ ｩ ｯ ｮ ｳ produced only a
20% response rate [28J.
In their study of hreast cancer screeninq, Shapiro et ale [29J
founel tho. t those women who refused S·Ci. eellina \'lere, in aeneral,
slightly older, had a lower educational attainment and were less likely
to be Jewish, to have been married or to be multiparous or prerneno-
pausal. Once aoain, however, rfltes of ｲ ･ Ｍ ･ ｸ ｡ ｾ ｩ ｮ ｡ ｴ ｩ ｯ ｮ were influ-
0flced only nf'!9liqibly by aqp; nor were they ｩ ｮ ｦ ｾ ｵ ･ ｮ ｣ ･ ､ hy
educational attainment, race or menopausal stat11s.
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!ltti tucUni1l T·"1ctors
screen.ed,
For a nerson to present ｨ ｩ ｬ ｾ ｓ Ｐ Ｑ ｦ to he Rcreen1Mq, he ｾ ｵ ｳ ｴ
I
in many cases he aware of ｰ ｯ ｳ ｳ ｩ ｢ Ｉ ｣ Ｚ ｩ ｬ ｬ ｮ ｾ ｳ ｳ ･ ｳ Ｌ heljeve thnt a
screening proqram may help hi1"'\ i'lnd 11e \-Tilling to COIne fan-lard. This
is not to say that in some cases there micrht not he screen ina
proqrams in which a person Dart.icipates because it is easier to
do so than not to or that one miaht not have a screenina proqrarn
which offered larqe enticements to take port. In general, hm"ever,
personal attitudes tOHarns illness and medical care can be expected
to play a large role in deterMininer whether ann when a person cornes
ｦ ｯ ｮ ｾ ｡ ｲ ､ to he screened.
The Australian study founn that test-seekinq and worry ahout
cancer were related. In tHO other stunies it was founel that those
women \-1ho reported havinq a ｬｕｉｾｰ in their hreast were more likely
to have ｓ ｏ ｕ ｾ Ｑ ｨ ｴ screening [29J [251.
This leans into the question of health enucation and the
extent to which people's awareness of disease and their attitudes
to medical care can be altered in the short or long term. Clearly,
health education is a process which takes place informally as
well as formally but the relationshin betHeen forMal expenditures
on health education and attitUde changes is far from clear as
are the means of increasinq informal education e
Orqaniznt.ional and Institutionnl C'hnracteristics
'1hile health education may try ｾ ｯ alter neople's perceptions
of di5i":d 50 and a lli Ludes tu rne(1..ical care, there is usually for a
given proqram a SOMewhat more humble publicity activity. 'T'he
effectiveness of various forms of publicity in encouraqing parti-
the Kaiser-Permanente trial of multiphasic screeninq an experimental
group WAS attracted by beinq telenhonen at ｨ ｯ ｾ ･ and askcn to come
for a screenina spssion, \'!hile the control erroup consisten of (}
simi lax qroup of neoplr. not so ｰ ｮ ｃ ｏ ｕ ｲ ＼ ｬ ｃ ｔ ｐ ｾ Ｎ In the event, 60% of
th0S0 h>lr>ph0n0 r1 ('.:"1m,,:, fOl,,,,?:c n ＱﾷＧＡｾＮｩＮＺｌｃｬ 0nIy Ｒ Ｐ ｾ 0f t:he control
I
gro up came foni.-: n1 in tho norI'1ul \!(lY [30]. It does not seet.",
however, that until now experiments have been carried out to
test the effectiveness of various forms of ｰ ｬ ｾ ｬ ｩ ｣ ｩ ｴ ｹ in a controlled
m<lnner.
An alternative or complementary method of encouraainq parti-
cipation lies in payments to doctors or natients, blearly one
factor uffectina ｴ ｨ ･ ｾ ｸ ｴ ･ ｮ ｴ to \<7hic11 c90ctors will attempt to
ｾ ｳ the ･ ｾ ｴ ･ ｮ ｴ to which they are recompensed for doing so.
persui"l.de t11elr paticLts to be screened for a condition UK
([acton; receive a special fee, for example, for carryinq out a
cervical cancer ｳ ｾ ｲ ･ ･ ｮ ｩ ｮ ｱ test and it is often alleqed that the
reason for the poor penetration of cervical cancer screenina in
certain arOUDS of the population is attrihutahle to the smallness
of the fce.
In Austria, a scheme was ｩ ｮ ｴ ｲ ｯ ､ ｵ ｣ ｑ ｾ in 1974 whereby mothers
are given stipends continqent on their attendinq a specified
nl.lmher of ante-natal, post-nutal ancl child development clinics.
The stipend is considerahle,amountina in a year to the ｾ ｯ ｮ ｴ ｨ ｬ ｹ
wage of un averaqe worker. It is expected that this will ensure
near 100% participation in such cases.
A further ir1portimt fe<1tnri': ,.,hich may affi"ct participation is
the manner in "lhich a screeninq nroCJram is insertGG into thc
medical care systePI. Cervical cancer screeninq proarans, for
.
ｾｾｾｾｾｰｬ｣Ｌ ｣ｾｮ be ｣ ｾ ｲ ｲ ｩ ｣ ､ cut hy ｦ ｾ ｾ Ｑ ｩ ｬ ｹ ､ ｯ ｣ ｴ ｯ ｲ ｾ ns ｾ __ ... A.....: -...L \.J l.f. '-.L.1 1 'C ｾ ).1...... .1
cedurc or as a spccial effort; they can be carried out by hospitals
or public ｨ ･ ｡ ｬ ｾ ｣ ｬ ｩ ｮ ｩ ｣ ｳ ［ they can be carried out by medically
t-r"1ined persons or bv pararnedir..'11s. 7\11 of ｴ ｨ ･ ｾ ･ SVstPP1S hClVP.
advantages and ､ ｩ ｳ ｡ ､ ｾ ｡ ｮ ｴ ｡ ｱ ｣ ｳ Ｎ As far as their effects on parti-
cipntion i1re concerned, hov;cvpr, tlwre is J'1llcl1 suppositon but
little hard evidence.
Wilsorl b1] ｳｾ｡｡･ｳｴｳ that moves to make a ｳｾｲｰｰｮｩｮｮ ｰｲｮｮｲｾｾ
more acceptahle by health ･ ｾ ｵ ｣ ｡ ｴ ｩ ｯ ｮ ｬ ｾ ｩ ｱ ｬ ｬ ｴ he ｡ ｲ ｾ ｡ ｴ ｬ ｹ aided hy ｾ ｯ ｶ ｣ ｾ
to ｾ ｡ ｫ ･ the test itself more ncceptahle and he cites the ｣ ｾ ｳ ･
of ｳ ･ ｬ ｦ Ｍ ｡ ､ ｾ ｩ ｮ ｩ ｳ ｴ ･ ｲ ･ ､ cervical cytology tests. Glass and TIich [32]
found, however, that in the case of a "captive" population such
as school children, one form of self-ac'lministereo test, at any
ｲ ｡ ｴ ｾ ｰ ｲ ｯ ､ ｵ ｣ ･ ｾ a lower rate of participation in a screening
far\. ..program ｾ !Jacterlurla.
There is a large amount of literature concernina the effect
of distance on the use of ｭ ･ ､ ｾ ｣ ｡ ｬ care facilities. Some of this
has been reviewed by Shannon et £11. D3}. Little or none of this
work relates to screeninq ner se and the effecton screenina may
be expected to differ somewhat from consultation for' illness.
Girt ｾ ｾ Ｌ for example, found that the exnected neaative effect of
distance on consultation was offset to some extent by the fact
that individuals are likely to be more sensitive to the develop-
ment of disease the farther they live from a physician. His curves
reJ.ating consultation rates for various diseases to distance from
the general practitioner tend therefore to have a peak at a few
miles distance from the general practitioner. One might expect
that the offsetting effect would he less pronounced in the case
of screening and this appears to he borne out from his limited
evidence.
..
Tn ?ny ｾ ｡ ｾ ･ it ｭ ｡ ｾ Ｇ be ･ ｾ ｰ ･ ｣ ｴ ･ ｾ that the locaticn of -,..:"""'.;-,.. -"'--" ............. l-l-vu
-
and the time and inconvenience associated with attending - Ｌｾｩｬｬ
significantly affect pttendance and reattendance.
to have some effect on participation in screening proqrams. A
ｲｾｶｩ｣ w of the Ii terilture indicntes that in most cases little or
nothinq llns heen done ｳ ｹ ｳ ｴ ｣ ｾ ｮ ｴ ｩ ｣ ｡ ｬ ｬ ｹ to measure these ｦ ｾ ｣ ｴ ｯ ｲ ｳ and
to relate thesp eftects to the costs 0 1' srrcpninn for rlisease,
although a larqe amount of informal experience appears to exist
about the rates of partic5.nation to be expecten in screeninq
programs I> 5.1 •
We would propose as a preliminary step the cateqorization of
a large nur'ib('?r of screeninq proararrlS, principally cervical cancer
screening programs, ｡ ｣ ｣ ｯ ｲ ｾ ｩ ｮ ｮ to the nomoqraphic and orqanizationRl
factors list.ed here. Depen(Unq on'the results obtained fro!"" this
preliminary survey, we would propose atternptinq hy fOrPlal multi-
variate Methods and informa] analytical methods to relate the
ｰ ｾ ｲ ｴ ｩ ｣ ｩ ｰ ｡ ｴ ｩ ｯ ｮ of various r'1emoQrap}lic qroups in different programs
to orqani za'\icnal and, \<lhere possihle, atti tucUna 1 drtta. In the
case of snch a variohle as distance sufficient variation IT'icrht
exist wi thin s in(11e programs to pCTITli t esti"1(] tes of its effect.
It is very likely' that for a number of variahles there would not
exist sufficient variation to permit unamhiquous conclusions, but
we helieve ｴ ｨ ｾ ｴ eV0n a small ｩ ｾ ｄ ｲ ｯ ｶ ･ ｭ ｰ ｮ ｴ in our ｫ ｮ ｯ ｷ ｬ ･ ､ ｱ ｾ of the
effects of such fact0rs could he ･ ｸ ｴ ｲ ･ ｾ ･ ｬ ｹ useful in plRnninq
screening programs.
The offer of PHO to approach a lvrqe numherof cervical cancer
programs for us could provide us with a very useful source of
dilta.
.,
4. Optimizing the Scrcenina Policy
The purpose of the ｯ ｰ ｴ ｩ ｭ ｩ ｺ ｡ ｾ ｩ ｯ ｮ model is to determine
the best screening policy to adopt as a function of the
population to be served, and the resources available for
screening. This model will not consider ｰ ｾ ｯ ｢ ｬ ･ ｭ ｳ of time-
phasing, such as the capital investment needed in training
facilities or the preparation necessary to convince the
population to participate. Rather, it will be assumed that
the program has been in operation for many years, and that
the composition of the population, and the prevalence and
incidence of the disease, have reached their steady-state
values. Thus, this model will choose ｯ ｮ ｬ ｶ ｾ the best steady-
state situation •
.
The simulation model discussed in
the next section will help determine reasonable paths from
a given initial state to the desired steady state.
The elements of the optimization model are the variables
that describe the policy chosen, and functions of those
policy variables that describe the impacts. Policy variables
include such things as:
1) Which test should be used (e.g. cytology; enzyme)
2) Who should ｡ ､ ｾ ｩ ｮ ｩ ｳ ｴ ･ ｲ it (physician, nurse, para-
medical person)
3) Who should be screened and how often (see previous
ｾ
section)
4) What ･ ｦ ｦ ｯ ｾ ｴ ｳ should he devoted to following up
positive responses to the test (e.g. send letters,
make phone calls, make visits).
Impacts include:
1) ｐ ｨ ｹ ｾ ｩ ｣ ｩ ｡ ｮ ｇ Ｇ time
2) Nurses' amd paramedics' time
3) Training facilities for necessary personnel
4) Equipment fa carrying out screening test7
5) Hospital heds required--(i.e. patient load due
to screening program)
6) Time (and money) spent by participants in therprogram
7) Mortality from cervical cancer
These lists are not intended to be exhaustive.
Item '7) in the list of impacts--morta1ity from cervical
cancer--is only one possible measure of the benefits to be
derived from a screening program. Another possibility would
be the expected number of Homan-years of additional life due
to the program. Other measures might be constructed that would
reflect changes in morbidity--e.g. complications from radiation
therapy or hysterectomy--with which the program would be
credited.
Measures of benefit are important to the optimization
process, since we intend to choose one, which we will then
maximize. Which one we choose may influence the results to
a considerable degree. (We also intend to investigate the
sensitivity of the results to changes in the function.) For
example, if ".ve choose to maximi ze years of snrvi VFl 1: t-hp ()"[lH )Tl.::ll
policy may exclude virtually all screening activities for women
over (say) 70 years. After all, these women are not expected
to live very ｬ ｯ ｮ ｧ ｾ ･ ｶ ･ ｮ without cancer of the cervix. Yet to
choose mortality as our measure of henefit may imply that He
should concentrate our efforts on this re1atjvely high-risk
group, to the exclusion of young or rniad1e-aqed women.
ｾ｜ｔ･ wi 11 not COl'lpute an op Limal policy simply hy ｲ ｲ ｉ ｃ ｬ ｾ ｩ ｆ ｜ ｩ ｺ ｩ ｮ Ｈ Ｑ
})0nefits. ｐ ｾ ｴ ｨ ･ ｲ we shall ｣ ｯ ｮ ｾ ｴ ｲ ｾ ｩ ｮ our policv hy ｬ ｩ ｾ ｩ ｴ ｩ ｮ ｱ
its resource costs. "'hus ",re' l"<'ly require thc'l.t only a lind ted
dl;)Ount of the physicizll1' s time' he take hy screeninq activities,
or that a patient not be renuired to travel more than 10
kilometers to receive her test, or that the total screenina
budget not exceed a certain ｮ ｵ ｾ Ｉ ･ ｲ ｯ ｾ dollars. ｉ ｮ ｾ ･ ･ ｾ Ｌ any
impact ｴ ｨ ｾ ｴ is a cost in the most qeneral sense ,r1lay provide
a constraint on the set of admissible policies.
Of course, these impacts will depend on the medical
environment in which the screeninq proqram is irnpleP.1.enteo.
For example, in a ｰｬｩＱ｣Ｈｾ \'lhere people are medically serven.
onJ.y hy a few large hospitals and clinics, to set up small,
nei ghborhooc1 screeninq faci Ii ties ,'muld be very expensi're.
nut where neiqhborhood clinics already exist, the screening
test could be offered there at little additional cost. It
might prove optimal in'fue first case to ｰ ｲ ｯ ｶ ｩ ｾ ｣ a few mohile
screening fa.cili ties, housed: in large trucks, whi Ie it would
probably be hetter to dispense screenina tests through the
existinq clinics in the second case.
Data from which resource requirements can he estimated
are probahly best ohtained directly from administrators of
existing ,screening proqrams. We expect to take advantage of the
offer of mlO to approach such proqrams for us and effect their
).
e.i0 ｩ ｾ this rege.rd. In andition, ｳ ｯ ｾ ･ 0e.ta on costs exists ｩ ｾ
the published literature (see, for example l22,36]). Benefits,
on the other hand, ,,,ill be calculated using our m"n models of
Ｋ Ｎ ｾ Ｌ ｰ disease process, in a manner similar to Knox[1,2].
Given an optimal policy, one would wish to explore the
consequences of chc:nqi.nq the (tsslll-nntions involvc(l in pror1uciIlCf
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it. For the policy is optimal only under the circurlstances
in which it is calculated. Thus we may ask whether ｾ ｡ ｮ ｱ ･ ｳ in
+-l-.c cc.,.. ..... ｣ｳｾＫＭｾｯｾ ｾｾ ｾＧＭｾ ＭＭｩＮｬｬ｡ｾｬﾷＭＭ --. l'n ,,-- '11'""l'(lel-C of tl-"
'-u "'I'-' -'- <--'- H ＧＭＧｾＬ <-He: Ａ Ｇ Ｍ Ｂ ＾ ｾ ＾ , L. \.)U, 'I.L ! L.lle J, l. I e _ Ie
disease will greatly ､ ･ ｱ ｲ ｾ ､ ･ the performance of the screening
system. Or we may eXPlore the effect of assuminq a higher (or
lower) false neqative rate of the screeninq test. ｾ Ｇ Ａ ･ ,."ould
hope to find policies that are not only optimal, or nearly
optimal, but which remain nearly optimal when the assumptions
are changed.
Such exploration can provide measures of the value of
new technologies or policies that are not explicitly included
in the model. Thus, one may ask how much one should pay to
improve the prognosis of cases of invasive cancer by a stated ｡ ｾ ｯ ｵ ｮ ｴ Ｎ
If the proqnosis is improved, one will be able to reduce the
size (and hence the cost) of the screening proqram while main-
taining the total benefit (e.q. reduced mortality) unchanged.
The reduction in screening cost is then a measure of the value
of improving the proqnosis.
Or one may estimate the value of techniques for enticinq
exactly the desired groups within the population to participate.
One first solves the problem allowinq oneself to choose any
such population at all from amonq the whole population. Thus,
one may specify that every ｷ ｯ ｾ ｡ ｮ over 45 years of ｡ ｱ ｾ with an
income (or family's income) under $6000 per year shall he
screened at one year intervals, ｷ ｨ ｩ ｬ ｾ women of the same ages but
richer would be screened every eighteen months. Then one can
solve the same problem, but permit participation only by groups
of realistic composition (see previous section). The resources
ｵ Ｚ Ｍ ｌ ［ ｾ in the t\-;ro Ctlses would he adj nsten unti 1 the benefits
were equal, tlneJ the di fference in' the resources would be the
value of an ahili ty to reach exactly the desired pormlation.
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Finally, a cyuestion of cqui ty ari ses. It may he the case
that t'.,!O differcEt qr01J.pS of ｾ Ｇ ｔ ｏ ｲ ｮ ･ ｮ l.,; l' he
··1 ................... ｳｩｾｩｬ｡ｲ in terms
of risk of cervical cancer, and similar in terms of socio-
economic status, hut that it will be ontimal to treat them
differently. For example, to screen the rural population may
require a mohile clinic that can accoMPlish only a few dozen
screening tests a day, due to the time spent travellinq. The
same mobile clinic might accoJTl.olish several hundred tests among
comparahle women in an urban reqion and hence be "better"
employed there. But is this fair? Althouqh we have no magic
method for resolvinq this question, we can at least calculate how
much reduction in benefits or increase in cost an attempt to
be fair will require.
ＭｾＭ
5. Time-Phasinq ｾ ｮ ､ Imolcmpntation
We ｰｲｯｰｯｾ･ to ｣ ｯ ｮ ｾ ｴ ｲ ｵ ｣ ｴ or adapt a ｳｩｾｵｬ｡ｴｩｯｮ reodel (e.q. the
model of Knox ｛ Ｑ Ｌ ｾ ｊ Ｉ to study questions of tiMe-phasinq and im-
plementation of a screening proqram. These questions include:
o How, and how quickly, are the necessary resources (e.q.
cytologists and cytoloqy facilities) to he mobilized?
•
o How quickly are efforts to attract participants in the
program to he iMpleMented?
o What will be the changing needs of the proqram from the
first ｾ years, when it is dealing with the backlog of
prevalent cases, to later years, when it is locating only
the incident cases?
o What will be the impact on the proqram of variations in
the incidence of the disease or participation in the
program?
Ouestions of this kind are not dealt with in the framework of
the optimization problem, hecause to do so would require that the
model be tOG large. Instead, we will indentify prefered policies
using the optimization Model and assuminq a steady-state (hence
ｾ ｭ ｳ ｴ ｡ ｮ ｴ Ｉ participation, level of screening effort, and disease
incidence. Then, to explore possible rlifficulties in arrivinq
at those policies, and potential problems in returnina to a
steady state following a perturhation, we resort to a simulation
approach.
Mobilize Res6urces
Depending on the situation ｩ ｮ ｾ ･ region setting up a
screening ｾ ｲ ｯ ｱ ｲ ｡ ｭ ｲ nne or anothernf the ｮ ･ ･ ｾ ･ ､ resources may qovern
the rate at which the screening service can expand. ｾ ｯ ｲ Ｌ
example, this critical resource could he trained cytoloaists.
ＭｾＭ
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ｾｨ･ rate at which ｳ ｾ ｣ ｨ people can be made availahle will gener-
ally depend on the size of the existinq traininq facilities,
and the rate at which those facilities can be auqmented and
staffed. Models treating such a situation are Ｌ Ｎ Ｌ ･ ｬ ｬ Ｍ ｫ ｮ ｯ ｾ ｭ {for
example, see [37}, p. 57 andl3S], p. ｊ Ｘ Ｓ ｾ Other resources are
cytology facilites, perRonnel and facilities for carryinq out
the screeninq test, and personnel and facilities for followinq
up those women whose tests are positive.
We have been writinq as thouqh the test to he used is the
PAP smear. of course, other tests are possible - e.q. for the
enzyme 6-phosphoqluconate dehydroqenase ｛ Ｓ ｾ Ｍ ｡ ｮ ､ Ｌ if used,
would require that somewhat different resources be mohilized.
However, the problem will be the same in principle, reqardless
of the test employed.
ｾ ｴ ｴ ｲ ｡ ｣ ｴ Participants
The time dimension is involved in attractinq participants
into the program as well. First, measures taken to attract
people (e.q. educational advertizinq campaiqns, see section 3)
will require some time to take effect. ｾ ｨ ｡ ｴ is, there is a
practical limit to how fast participation can be increased.
Second, one must take care that these measures do not cause
participation to exceed the capacity of the system. This could
discourage many from ioining the proqram later, when facilities
become adequate. In short, one shoJld coordinate the technical
aspects of setting up the proqram - i.e. mobilization of resources -
with the social aspects - i.e. attracting participants.
This requirement for coordination miqht best be met by
constantly expandinq the taraet population of the screeninq
program. While the proaraM is sMall, one miqht aim it only at
those people who are both at qreatest risk from the disease and
most accessihle tO,the screening facilities. As the proqram grows,
both those at less risk and those less Accessihle \o1oulo more and
more be enticed into the proqram.
Approach to ｾ ｴ ･ ､ ､ ｹ Ｍ ｓ ｴ ｡ ｴ ･
Prior to the start of the screeninq proqram, there will
exist in the population a pool of early cases that in the usual
course of events would proqress in the next several years to the
late, invasive stage. ｾ ｶ ｨ ･ ｮ the screeninq program is first imple-
mented, it will discover the cases in this pool. The treatment
required hy these cases constitutes an ,unaccustomed burden upon
the health care system. At the same time, those cases of in-
vasive cancer that would have appeared in the absence of the
screeni,ng ｰ ｲ ｯ ｧ ｲ ｡ ｾ still appear in spite of its presence. For
them, screening has come too late. ｾ ｨ ｵ ｳ initially, the health
care system must cope with its usual burden of late cases,
plus the new tasks of screeninq and of treatinq early cases.
After several years, however, one expects to See a reduction
in the numher of invasive cases. This is due to the fact that
years before,the early cases were arrested that would otherwise
have proqressen to todav's late cases. Furthermore, the pool
of early cases that existea at the heqinninq of theproqram will
have been depleted. Poach year, the program will need to deal
only with early cases that developed the year hefore, rather than
'"dealing - as the proqram did initially - with an accumulation of
years of early cases. Thus the capacity of the health care ｳ ｹ ｳ ｴ ･ ｾ
to deal with both early and late cases should he considerahly
larger early in the proqram than later.
The fact that benefits are delayed and that the early costs
of the program are larqe raises another interest point. One
presumes that a henefi t delayed is "JOrth less than the same
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b0nefjt achieved sooner. Thnt is, one discol1nts future benefits
(and costs) in comparison with present ones. If one accepts
this point of view, the fact that resource costs are felt ･ ｡ ｾ ｬ ｹ
in the program, while benefits appear only later, Might lead one
not to institute the program, even thouqh the exnected steady
state is preferred to the present situation. Of course, such a
conclusion '1ill depend on the discount rate one chooses. A
low discount rate will lead one to hear the present costs in order
to receive future benefits; a hiqh rate will cause one to foreqo
both. A discount ｲ ｾ ｴ ･ of 10% per year is widely accepted for
decisions in which benefits and costs are all Monetized (see 80J,
p. viii), but who is to say the same rate is applicable to years
of survival L41]?
Uncertainty
At the heginninq of a screening proqram, plans will he drawn
up on the basis of assumed. or expected. rates 0f incidence of
carcinoma in-situ amonq different seqments of the population.
- .'
These estimates will undouhte(Uy include some error, and perhaps
a great deal. During the course of the program, direct measurements
of incidence will be made, and will no douht call for adjustments
in the screening policy. ｾ ｨ ｯ ｳ ･ ad;ustMents can be made relatively
painless by choosing an impLementation strategy that takes into
account their likelihood.
Furthermore, one shoulu pxpect Uli::t i.. . iilciJefl i.. rates will
change from one cohort to women to another [9,101. Fven after
the program has been in effect for many years, continued ｡ ､ ｪ ｵ ｾ ｴ Ｍ
Participation rates will a).so chanqe from time to time.
cancer in the Uniterl States. ｾ ｨ ｩ ｳ increased interest is s11rely the
result of Mrs. Ford's and ｲ ｾ ｲ ｳ Ｎ ｐ ｯ ｣ ｫ ･ ｾ ｰ Ｎ ｬ ｬ ･ ｲ Ｇ ｳ operations, and can
be expected to die away over the next few. months or, at most,
the next few years.
Financial support ｦ ｯ ｲ ｾ ｬ ･ proaram might also suffer sudden
chanqes. The appearance of sudden interest in a proQram miqht
yield increased private donations or, more slowly, increased
government support. Similarly, if a proqram's results fall short
of expectation, its fundinq might suffer. The screenina proqram
should be designed so that such shifts will not cripple it.
Dynamic Nature of Circumstances
Few things in human experience are constant. We must be
prepared to cooe not only with the averao,e or expected situation,
but with the variations in the situation that we know will occur.
The optimization model that we proposed in section 4 flcals only with
the average situation. It requires a simulation model to ensure
that policies considered optimal in section 4 will still be good
policies in the real world.
I
scribe a number of studies which \'le believe would aid the formulation
of policy tm..;ards ｳ ｃ ｲ ｅ ｾ ･ ｮ ｩ ｮ ｃ ｔ for cervical cancer. rr'hese studies
would contrihute to mooels which \..;ould he useful for countries
which have already created screening nroqrams or in which screening
programs have qrown up without conscious political decisions.
The models would be useful also for countries which are contemplating
cervical cancer programs. Finally the ｾ ｯ ､ ･ ｬ ｳ could serve as
prototypes for other diseases where screeninq proarams are under
contemplation.
The models we hope to develop are ones hy means of which the
conseauences of changes in nolicy could he tested. For countries
in which cervical cancer screening programs exist already the
"political" costs and benefits of reducing or expandinq the proaralR
will prohably be only too evident to ｾ ･ ､ ｩ ｣ ｡ ｬ poliCy-Makers. What
they may not knoH are the Medical and econoM.ic consequences of
such decisions. ｾ ｯ ､ ･ ｬ ｳ which trace through such conseauences
should make a vital contribution to policy discussions.
Administrations or organizations contemplating the establish-
ment of cancer screening proqraMs also need to kno\o' what consequences
are likely to flow from such a decision and can they design a program
which will hest meet their ob;ectivps suh-ject to the constraints
on manpower and physical resources Ni th which they are facecl?
r
Should they ｩ ｾ ｌ ｾ ｵ ｊ ｵ ｣ ･ a ｾｲｯｱｲ｡ｭ at ｡ ｬ ｬ ｾ If so, how Quickly should
it be introduced? These are questions which can best be anm'lered
by testing and evaluating a numher dE alternatives.
programs occur also in connection with screeninq for other diseases.
One prohlem ip particular is that of estimating the period of time
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clur iner which Cl. partiel,l 2r conr1 i tion ｲ Ｈ ｾ ｲ ｮ Ｎ ｡ Ｚ ｩ ns at a Pl."p··cri tic;) I
level as is the case 111 ｣ ｣ ｲ ｶ ｩ ］ ｾ ｬ ｬ ｣ ｮ ｮ ｣ ｾ ｲ Ｎ This piece of informn-
tion as we ht'lVe indicated is vitil.l to the desicTn of screeninq
prorrraJ11S, especially the determination or: the scrf'cning interval.
Establishment: of such inf'ormCltion hy retDrlornized controlled trials
is often very costly and sloH, if not imnossible. rrhe r.eveloprn.cnt
of a methodoloqy for ･ ｳ ｴ ｩ ｾ ｡ ｴ ｩ ｮ ｱ the natural history of the
disease in its prc··critico11 stElerF' hy methods othr:r theHl those
of a purpose-built trial. could he a J110st useful ｰ ｾ ｯ ｾ ｵ ｣ ｴ of this
work and Might have applicntion in ｾ ｨ ･ ｲ diseases (e.n. chronic simple
qlaucoma) •
All scrGeninq nroqrams encounter the prohlRJ11 of inducinq
public participation. Vet there is little evidence on the
effectiveness and efficiency of various methods of encoUra0inq
participation ill screening proqraJ11S among various groups of the
population. Clearly, ｨ ｲ ｮ ｾ ･ ｶ ･ ｲ Ｌ it is difficult to make ｰ ｬ ｡ ｮ ｮ ｩ ｮ ｾ
､ Ｈ ｾ ｣ ｩ ｳ ｩ ｯ ｮ ｳ without such information. ()ur research prospectus pn>-
poses thRt t·:e consicle:r systeplatic"llly methods of obtaininq such
cIa ta, Ｈ ｾ ｳ ｰ ･ ｣ ｩ ｡ ｬ ｬ ｹ in the Ci'lse or- cervical screeninq.
The siMulation and optimizRtion ｭ ｯ ､ ･ ｬ ｾ provide the frameworks
for analyzinq hoth tte best choices qiven our ohjPctives and
constraints and the ｰ ｲ ｾ Ｉ ｬ ･ ｍ ｳ involved in rcachinq the preferred
solutions. 1\1 t.houqh sip1lllation models have ｨ ･ ｦ Ｇ ｾ ｮ applien to the
analysis of screening ｰ ｲ ｯ ｧ ｲ ｾ ｾ ｳ for cervical. cancer, this is not
the case, as far as we can ｡ ｳ ｣ ｣ ｾ ｴ Ｐ ｩ ｮ Ｌ for an optimization nodel.
Furthermore, the simulation monel out.lined here is far more
oriented tOHo.rds policy questions than earlier examples.
of course, atteMpts to PlonRI complex policy questions are
｢ ｯ ｵ ｮ Ｈ ｾ to }")e l1indE're(1 ｨ ｾ Ｑ ('1jff:ic1l1t-jn s of ohtrd.ninrr r:at:;;. :7(\
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that the methods of avercorninrf them will have useful applications
elsewhere - especially when it is ｨ ｾ ｲ ｮ ･ in ｾ ｩ ｮ ､ ｴ ｨ ｾ ｴ screeninq
programs, their desiqn and implementation, are likely to be of
increasing concern to health services everywhere.
Rcfcr0JlCCS
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